{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T03:59:18Z","timestamp":1791518358328,"version":"4.3.4"},"reference-count":202,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T00:00:00Z","timestamp":1772841600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T00:00:00Z","timestamp":1772841600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Celularity Inc."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov. Immun."],"DOI":"10.1007\/s44368-026-00021-2","type":"journal-article","created":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T06:53:32Z","timestamp":1772866412000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The therapeutic potential of natural killer (NK) cells to combat aging and age-related diseases"],"prefix":"10.1007","volume":"3","author":[{"given":"Rafijul","family":"Bari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Gosiewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J","family":"Hariri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,7]]},"reference":[{"issue":"1","key":"21_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-022-01251-0","volume":"7","author":"J Guo","year":"2022","unstructured":"Guo J, Huang X, Dou L, Yan M, Shen T, Tang W, et al. Aging and aging-related diseases: from molecular mechanisms to interventions and treatments. Signal Transduct Target Ther. 2022;7(1):391. https:\/\/doi.org\/10.1038\/s41392-022-01251-0.","journal-title":"Signal Transduct Target Ther"},{"issue":"4","key":"21_CR2","doi-asserted-by":"publisher","first-page":"835","DOI":"10.5604\/12321966.1129943","volume":"21","author":"M Dziechcia\u017c","year":"2014","unstructured":"Dziechcia\u017c M, Filip R. Biological psychological and social determinants of old age: bio-psycho-social aspects of human aging. Ann Agric Environ Med. 2014;21(4):835\u20138. https:\/\/doi.org\/10.5604\/12321966.1129943.","journal-title":"Ann Agric Environ Med"},{"issue":"10","key":"21_CR3","doi-asserted-by":"publisher","first-page":"25392","DOI":"10.3390\/ijms161025392","volume":"16","author":"MH Yun","year":"2015","unstructured":"Yun MH. Changes in regenerative capacity through lifespan. Int J Mol Sci. 2015;16(10):25392\u2013432. https:\/\/doi.org\/10.3390\/ijms161025392.","journal-title":"Int J Mol Sci"},{"issue":"15","key":"21_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare11152131","volume":"11","author":"S Noto","year":"2023","unstructured":"Noto S. Perspectives on aging and quality of life. Healthcare. 2023;11(15):2131. https:\/\/doi.org\/10.3390\/healthcare11152131.","journal-title":"Healthcare"},{"key":"21_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fnhum.2023.1274151","volume":"17","author":"L Piccardi","year":"2023","unstructured":"Piccardi L, Pecchinenda A, Palmiero M, Giancola M, Boccia M, Giannini AM, et al. The contribution of being physically active to successful aging. Front Hum Neurosci. 2023;17:1274151. https:\/\/doi.org\/10.3389\/fnhum.2023.1274151.","journal-title":"Front Hum Neurosci"},{"key":"21_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2025.102784","volume":"111","author":"S Elhag","year":"2025","unstructured":"Elhag S, Niechcial MA, Potter L, Gow AJ. Exploring the impact of community-based interventions on healthy older adults\u2019 physical health, psychological wellbeing, and social connections: a systematic review. Ageing Res Rev. 2025;111:102784. https:\/\/doi.org\/10.1016\/j.arr.2025.102784.","journal-title":"Ageing Res Rev"},{"issue":"1","key":"21_CR7","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s40520-025-03021-8","volume":"37","author":"V Gianfredi","year":"2025","unstructured":"Gianfredi V, Nucci D, Pennisi F, Maggi S, Veronese N, Soysal P. Aging, longevity, and healthy aging: the public health approach. Aging Clin Exp Res. 2025;37(1):125. https:\/\/doi.org\/10.1007\/s40520-025-03021-8.","journal-title":"Aging Clin Exp Res"},{"issue":"4","key":"21_CR8","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s11357-018-0036-9","volume":"40","author":"M Kaeberlein","year":"2018","unstructured":"Kaeberlein M. How healthy is the healthspan concept? Geroscience. 2018;40(4):361\u20134. https:\/\/doi.org\/10.1007\/s11357-018-0036-9.","journal-title":"Geroscience"},{"key":"21_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1565278","volume":"16","author":"M Gergues","year":"2025","unstructured":"Gergues M, Bari R, Koppisetti S, Gosiewska A, Kang L, Hariri RJ. Senescence, NK cells, and cancer: navigating the crossroads of aging and disease. Front Immunol. 2025;16:1565278. https:\/\/doi.org\/10.3389\/fimmu.2025.1565278.","journal-title":"Front Immunol"},{"issue":"26","key":"21_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s12979-024-00451-2","volume":"21","author":"X Deng","year":"2024","unstructured":"Deng X, Terunuma H. Adoptive NK cell therapy: a potential revolutionary approach in longevity therapeutics. Immun Ageing. 2024;21(26):43. https:\/\/doi.org\/10.1186\/s12979-024-00451-2.","journal-title":"Immun Ageing"},{"issue":"2","key":"21_CR11","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s41571-020-0426-7","volume":"18","author":"JA Myers","year":"2021","unstructured":"Myers JA, Miller JS. Exploring the NK cell platform for cancer immunotherapy. Nat Rev Clin Oncol. 2021;18(2):85\u2013100. https:\/\/doi.org\/10.1038\/s41571-020-0426-7.","journal-title":"Nat Rev Clin Oncol"},{"issue":"8","key":"21_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-02005-w","volume":"9","author":"S Chen","year":"2024","unstructured":"Chen S, Zhu H, Jounaidi Y. Comprehensive snapshots of natural killer cells functions, signaling, molecular mechanisms and clinical utilization. Signal Transduct Target Ther. 2024;9(8):302. https:\/\/doi.org\/10.1038\/s41392-024-02005-w.","journal-title":"Signal Transduct Target Ther"},{"issue":"11","key":"21_CR13","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.50241","volume":"7","author":"A Garmany","year":"2024","unstructured":"Garmany A, Terzic A. Global healthspan-lifespan gaps among 183 World Health Organization member states. JAMA Netw Open. 2024;7(11):e2450241. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.50241.","journal-title":"JAMA Netw Open"},{"issue":"17","key":"21_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/cells11061017","volume":"11","author":"A Brauning","year":"2022","unstructured":"Brauning A, Rae M, Zhu G, Fulton E, Admasu TD, Stolzing A, et al. Aging of the immune system: focus on natural killer cells phenotype and functions. Cells. 2022;11(17):1017. https:\/\/doi.org\/10.3390\/cells11061017.","journal-title":"Cells"},{"issue":"21","key":"21_CR15","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.exger.2017.12.015","volume":"105","author":"A Bektas","year":"2017","unstructured":"Bektas A, Schurman SH, Sen R, Ferrucci L. Aging, inflammation and the environment. Exp Gerontol. 2017;105(21):10\u20138. https:\/\/doi.org\/10.1016\/j.exger.2017.12.015.","journal-title":"Exp Gerontol"},{"issue":"3","key":"21_CR16","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13094","volume":"19","author":"MJ Yousefzadeh","year":"2020","unstructured":"Yousefzadeh MJ, Zhao J, Bukata C, Wade EA, McGowan SJ, Angelini LA, et al. Tissue specificity of senescent cell accumulation during physiologic and accelerated aging of mice. Aging Cell. 2020;19(3):e13094. https:\/\/doi.org\/10.1111\/acel.13094.","journal-title":"Aging Cell"},{"key":"21_CR17","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ebiom.2018.09.015","volume":"36","author":"MJ Yousefzadeh","year":"2018","unstructured":"Yousefzadeh MJ, Zhu Y, McGowan SJ, Angelini L, Fuhrmann-Stroissnigg H, Xu M, et al. Fisetin is a senotherapeutic that extends health and lifespan. EBioMedicine. 2018;36:18\u201328. https:\/\/doi.org\/10.1016\/j.ebiom.2018.09.015.","journal-title":"EBioMedicine"},{"issue":"7","key":"21_CR18","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1016\/j.cmet.2024.03.009","volume":"36","author":"W Tao","year":"2024","unstructured":"Tao W, Yu Z, Han JJ. Single-cell senescence identification reveals senescence heterogeneity, trajectory, and modulators. Cell Metab. 2024;36(7):1126-1143.e5. https:\/\/doi.org\/10.1016\/j.cmet.2024.03.009.","journal-title":"Cell Metab"},{"key":"21_CR19","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1146\/annurev-pharmtox-050120-105018","volume":"61","author":"PD Robbins","year":"2021","unstructured":"Robbins PD, Jurk D, Khosla S, Kirkland JL, LeBrasseur NK, Miller JD, et al. Senolytic drugs: reducing senescent cell viability to extend health span. Annu Rev Pharmacol Toxicol. 2021;61:779\u2013803. https:\/\/doi.org\/10.1146\/annurev-pharmtox-050120-105018.","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"8","key":"21_CR20","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1038\/ncb1909","volume":"11","author":"F Rodier","year":"2009","unstructured":"Rodier F, Copp\u00e9 JP, Patil CK, Hoeijmakers WA, Mu\u00f1oz DP, Raza SR, et al. Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion. Nat Cell Biol. 2009;11(8):973\u20139. https:\/\/doi.org\/10.1038\/ncb1909.","journal-title":"Nat Cell Biol"},{"key":"21_CR21","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1146\/annurev-pathol-121808-102144","volume":"5","author":"JP Copp\u00e9","year":"2010","unstructured":"Copp\u00e9 JP, Desprez PY, Krtolica A, Campisi J. The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu Rev Pathol. 2010;5:99\u2013118. https:\/\/doi.org\/10.1146\/annurev-pathol-121808-102144.","journal-title":"Annu Rev Pathol"},{"issue":"16","key":"21_CR22","doi-asserted-by":"publisher","first-page":"4150","DOI":"10.1016\/j.cell.2024.05.059","volume":"187","author":"M Ogrodnik","year":"2024","unstructured":"Ogrodnik M, Carlos Acosta J, Adams PD, di d\u2019Adda Fagagna F, Baker DJ, Bishop CL, et al. Guidelines for minimal information on cellular senescence experimentation in vivo. Cell. 2024;187(16):4150\u201375. https:\/\/doi.org\/10.1016\/j.cell.2024.05.059.","journal-title":"Cell"},{"key":"21_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fragi.2022.900028","volume":"3","author":"KA Lee","year":"2022","unstructured":"Lee KA, Flores RR, Jang IH, Saathoff A, Robbins PD. Immune Senescence, Immunosenescence and Aging. Front Ageing. 2022;3:900028. https:\/\/doi.org\/10.3389\/fragi.2022.900028.","journal-title":"Front Ageing"},{"issue":"1","key":"21_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13192-4","volume":"10","author":"O Karin","year":"2019","unstructured":"Karin O, Agrawal A, Porat Z, Krizhanovsky V, Alon U. Senescent cell turnover slows with age providing an explanation for the Gompertz law. Nat Commun. 2019;10(1):5495. https:\/\/doi.org\/10.1038\/s41467-019-13192-4.","journal-title":"Nat Commun"},{"key":"21_CR25","doi-asserted-by":"publisher","unstructured":"Freizus N, Majewska J, Ovadya Y, Kopitman E, Porat Z, Mayo A et al. Cell surface ATP6V1B2 marks a subset of persistent senescent cells with increased resistance to apoptosis. bioRxiv preprint, https:\/\/doi.org\/10.1101\/2025.11.30.691415","DOI":"10.1101\/2025.11.30.691415"},{"issue":"3","key":"21_CR26","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.cger.2016.02.007","volume":"32","author":"T Bandaranayake","year":"2016","unstructured":"Bandaranayake T, Shaw AC. Host resistance and immune aging. Clin Geriatr Med. 2016;32(3):415\u201332. https:\/\/doi.org\/10.1016\/j.cger.2016.02.007.","journal-title":"Clin Geriatr Med"},{"issue":"1","key":"21_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01451-2","volume":"8","author":"Z Liu","year":"2023","unstructured":"Liu Z, Liang Q, Ren Y, Guo C, Ge X, Wang L, et al. Immunosenescence: molecular mechanisms and diseases. Signal Transduct Target Ther. 2023;8(1):200. https:\/\/doi.org\/10.1038\/s41392-023-01451-2.","journal-title":"Signal Transduct Target Ther"},{"issue":"12","key":"21_CR28","doi-asserted-by":"publisher","first-page":"4921","DOI":"10.1172\/JCI59777","volume":"121","author":"J Zhao","year":"2011","unstructured":"Zhao J, Zhao J, Legge K, Perlman S. Age-related increases in PGD(2) expression impair respiratory DC migration, resulting in diminished T cell responses upon respiratory virus infection in mice. J Clin Invest. 2011;121(12):4921\u201330. https:\/\/doi.org\/10.1172\/JCI59777.","journal-title":"J Clin Invest"},{"issue":"8","key":"21_CR29","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1038\/s41556-024-01465-0","volume":"26","author":"J Majewska","year":"2024","unstructured":"Majewska J, Agrawal A, Mayo A, Roitman L, Chatterjee R, Sekeresova Kralova J, et al. p16-dependent increase of PD-L1 stability regulates immunosurveillance of senescent cells. Nat Cell Biol. 2024;26(8):1336\u201345. https:\/\/doi.org\/10.1038\/s41556-024-01465-0.","journal-title":"Nat Cell Biol"},{"issue":"3","key":"21_CR30","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.4049\/jimmunol.1700397","volume":"199","author":"CK Wong","year":"2017","unstructured":"Wong CK, Smith CA, Sakamoto K, Kaminski N, Koff JL, Goldstein DR. Aging impairs alveolar macrophage phagocytosis and increases influenza-induced mortality in mice. J Immunol. 2017;199(3):1060\u20138. https:\/\/doi.org\/10.4049\/jimmunol.1700397.","journal-title":"J Immunol"},{"issue":"7","key":"21_CR31","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1016\/j.ccell.2023.05.006","volume":"41","author":"LI Prieto","year":"2023","unstructured":"Prieto LI, Sturmlechner I, Graves SI, Zhang C, Goplen NP, Yi ES, et al. Senescent alveolar macrophages promote early-stage lung tumorigenesis. Cancer Cell. 2023;41(7):1261-1275.e6. https:\/\/doi.org\/10.1016\/j.ccell.2023.05.006.","journal-title":"Cancer Cell"},{"key":"21_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1421062","volume":"15","author":"H Gao","year":"2024","unstructured":"Gao H, Nepovimova E, Adam V, Heger Z, Valko M, Wu Q, et al. Age-associated changes in innate and adaptive immunity: role of the gut microbiota. Front Immunol. 2024;15:1421062. https:\/\/doi.org\/10.3389\/fimmu.2024.1421062.","journal-title":"Front Immunol"},{"key":"21_CR33","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.mad.2013.11.007","volume":"135","author":"E Beli","year":"2014","unstructured":"Beli E, Duriancik DM, Clinthorne JF, Lee T, Kim S, Gardner EM. Natural killer cell development and maturation in aged mice. Mech Ageing Dev. 2014;135:33\u201340. https:\/\/doi.org\/10.1016\/j.mad.2013.11.007.","journal-title":"Mech Ageing Dev"},{"issue":"5","key":"21_CR34","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1111\/j.1474-9726.2012.00839.x","volume":"11","author":"J Hazeldine","year":"2012","unstructured":"Hazeldine J, Hampson P, Lord JM. Reduced release and binding of perforin at the immunological synapse underlies the age-related decline in natural killer cell cytotoxicity. Aging Cell. 2012;11(5):751\u20139. https:\/\/doi.org\/10.1111\/j.1474-9726.2012.00839.x.","journal-title":"Aging Cell"},{"issue":"4","key":"21_CR35","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1016\/j.arr.2013.04.003","volume":"12","author":"J Hazeldine","year":"2013","unstructured":"Hazeldine J, Lord JM. The impact of ageing on natural killer cell function and potential consequences for health in older adults. Ageing Res Rev. 2013;12(4):1069\u201378. https:\/\/doi.org\/10.1016\/j.arr.2013.04.003.","journal-title":"Ageing Res Rev"},{"issue":"4","key":"21_CR36","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/S0091-6749(03)02025-6","volume":"112","author":"CJ Hackett","year":"2003","unstructured":"Hackett CJ. Innate immune activation as a broad-spectrum biodefense strategy. J Allergy Clin Immunol. 2003;112(4):686\u201394. https:\/\/doi.org\/10.1016\/S0091-6749(03)02025-6.","journal-title":"J Allergy Clin Immunol"},{"key":"21_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01081","volume":"11","author":"T St\u00f6gerer","year":"2020","unstructured":"St\u00f6gerer T, St\u00e4ger S. Innate immune sensing by cells of the adaptive immune system. Front Immunol. 2020;11:1081. https:\/\/doi.org\/10.3389\/fimmu.2020.01081.","journal-title":"Front Immunol"},{"issue":"12","key":"21_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines12121314","volume":"12","author":"P Goyani","year":"2024","unstructured":"Goyani P, Christodoulou R, Vassiliou E. Immunosenescence: aging and immune system decline. Vaccines. 2024;12(12):1314. https:\/\/doi.org\/10.3390\/vaccines12121314.","journal-title":"Vaccines"},{"issue":"2","key":"21_CR39","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s10522-021-09910-5","volume":"22","author":"Z Li","year":"2021","unstructured":"Li Z, Zhang Z, Ren Y, Wang Y, Fang J, Yue H, et al. Aging and age-related diseases: from mechanisms to therapeutic strategies. Biogerontology. 2021;22(2):165\u201387. https:\/\/doi.org\/10.1007\/s10522-021-09910-5.","journal-title":"Biogerontology"},{"key":"21_CR40","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1186\/s12889-020-09693-3","volume":"20","author":"\u00c1 Lubl\u00f3y","year":"2020","unstructured":"Lubl\u00f3y \u00c1. Medical crowdfunding in a healthcare system with universal coverage: an exploratory study. BMC Public Health. 2020;20:1672. https:\/\/doi.org\/10.1186\/s12889-020-09693-3.","journal-title":"BMC Public Health"},{"key":"21_CR41","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/9171424","volume":"2019","author":"K Trevisan","year":"2019","unstructured":"Trevisan K, Cristina-Pereira R, Silva-Amaral D, Aversi-Ferreira TA. Theories of aging and the prevalence of Alzheimer\u2019s disease. BioMed Res Int. 2019;2019:9171424. https:\/\/doi.org\/10.1155\/2019\/9171424.","journal-title":"BioMed Res Int"},{"key":"21_CR42","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1001\/archneur.58.10.1611","volume":"58","author":"J Jankovic","year":"2001","unstructured":"Jankovic J, Kapadia AS. Functional decline in Parkinson disease. Arch Neurol. 2001;58:1611\u20135. https:\/\/doi.org\/10.1001\/archneur.58.10.1611.","journal-title":"Arch Neurol"},{"key":"21_CR43","doi-asserted-by":"publisher","first-page":"4329","DOI":"10.1111\/j.1582-4934.2009.00889.x","volume":"13","author":"R Donev","year":"2009","unstructured":"Donev R, Kolev M, Millet B, Thome J. Neuronal death in Alzheimer\u2019s disease and therapeutic opportunities. J Cell Mol Med. 2009;13:4329\u201348. https:\/\/doi.org\/10.1111\/j.1582-4934.2009.00889.x.","journal-title":"J Cell Mol Med"},{"key":"21_CR44","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.neurobiolaging.2012.06.009","volume":"34","author":"K Fabricius","year":"2013","unstructured":"Fabricius K, Jacobsen JS, Pakkenberg B. Effect of age on neocortical brain cells in 90\u2009+\u2009year old human females: a cell counting study. Neurobiol Aging. 2013;34:91\u20139. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2012.06.009.","journal-title":"Neurobiol Aging"},{"key":"21_CR45","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.pharmthera.2013.04.013","volume":"139","author":"GJ Harry","year":"2013","unstructured":"Harry GJ. Microglia during development and aging. Pharmacol Ther. 2013;139:313\u201326. https:\/\/doi.org\/10.1016\/j.pharmthera.2013.04.013.","journal-title":"Pharmacol Ther"},{"issue":"1\u20132","key":"21_CR46","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.jpsychires.2006.01.010","volume":"41","author":"E Richartz-Salzburger","year":"2007","unstructured":"Richartz-Salzburger E, Batra A, Stransky E, Laske C, Kohler N, Bartels M, et al. Altered lymphocyte distribution in Alzheimer\u2019s disease. J Psychiatr Res. 2007;41(1\u20132):174\u20138. https:\/\/doi.org\/10.1016\/j.jpsychires.2006.01.010.","journal-title":"J Psychiatr Res"},{"issue":"3","key":"21_CR47","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1159\/000017040","volume":"9","author":"SB Solerte","year":"1998","unstructured":"Solerte SB, Cerutti N, Severgnini S, Rondanelli M, Ferrari E, Fioravanti M. Decreased immunosuppressive effect of cortisol on natural killer cytotoxic activity in senile dementia of the Alzheimer type. Dement Geriatr Cogn Disord. 1998;9(3):149\u201356. https:\/\/doi.org\/10.1159\/000017040.","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"1","key":"21_CR48","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1007\/s12035-015-9644-x","volume":"54","author":"MS Garc\u00eda-Ayll\u00f3n","year":"2017","unstructured":"Garc\u00eda-Ayll\u00f3n MS, Botella-L\u00f3pez A, Cuchillo-Iba\u00f1ez I, R\u00e1bano A, Andreasen N, Blennow K, et al. HNK-1 carrier glycoproteins are decreased in the Alzheimer\u2019s disease brain. Mol Neurobiol. 2017;54(1):188\u201399. https:\/\/doi.org\/10.1007\/s12035-015-9644-x.","journal-title":"Mol Neurobiol"},{"issue":"23","key":"21_CR49","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1360687","volume":"15","author":"J Li","year":"2024","unstructured":"Li J, Zhang Y, You Y, Huang Z, Wu L, Liang C, et al. Unraveling the mechanisms of NK cell dysfunction in aging and Alzheimer\u2019s disease: insights from GWAS and single-cell transcriptomics. Front Immunol. 2024;15(23):1360687. https:\/\/doi.org\/10.3389\/fimmu.2024.1360687.","journal-title":"Front Immunol"},{"key":"21_CR50","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1002\/mds.25945","volume":"29","author":"T Pringsheim","year":"2014","unstructured":"Pringsheim T, Jette N, Frolkis A, Steeves TD. The prevalence of Parkinson\u2019s disease: a systematic review and meta-analysis. J Mov Disord Soc. 2014;29:1583\u201390. https:\/\/doi.org\/10.1002\/mds.25945.","journal-title":"J Mov Disord Soc"},{"key":"21_CR51","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1002\/cne.21333","volume":"502","author":"NM Kanaan","year":"2007","unstructured":"Kanaan NM, Kordower JH, Collier TJ. Age-related accumulation of Marinesco bodies and lipofuscin in rhesus monkey midbrain dopamine neurons: relevance to selective neuronal vulnerability. J Comp Neurol. 2007;502:683\u2013700. https:\/\/doi.org\/10.1002\/cne.21333.","journal-title":"J Comp Neurol"},{"issue":"s1","key":"21_CR52","doi-asserted-by":"publisher","first-page":"S83","DOI":"10.3233\/JPD-223212","volume":"12","author":"KB Menees","year":"2022","unstructured":"Menees KB, Lee JK. New insights and implications of natural killer cells in Parkinson\u2019s disease. J Parkinsons Dis. 2022;12(s1):S83-92. https:\/\/doi.org\/10.3233\/JPD-223212.","journal-title":"J Parkinsons Dis"},{"issue":"17","key":"21_CR53","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2021.686066","volume":"13","author":"Y Huang","year":"2021","unstructured":"Huang Y, Liu H, Hu J, Han C, Zhong Z, Luo W, et al. Significant difference of immune cell fractions and their correlations with differential expression genes in Parkinson\u2019s disease. Front Aging Neurosci. 2021;13(17):686066. https:\/\/doi.org\/10.3389\/fnagi.2021.686066.","journal-title":"Front Aging Neurosci"},{"key":"21_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-024-00652-y","volume":"10","author":"S Weber","year":"2024","unstructured":"Weber S, Menees KB, Park J, Agin-Liebes J, Lin CC, Alcalay RN, et al. Distinctive CD56dim NK subset profiles and increased NKG2D expression in blood NK cells of Parkinson\u2019s disease patients. NPJ Parkinsons Dis. 2024;10:36. https:\/\/doi.org\/10.1038\/s41531-024-00652-y.","journal-title":"NPJ Parkinsons Dis"},{"key":"21_CR55","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1161\/CIR.0b013e31820a55f5","volume":"123","author":"PA Heidenreich","year":"2011","unstructured":"Heidenreich PA, et al. Forecasting the future of cardiovascular disease in the United States: a policy statement from the American. Heart Assoc Circ. 2011;123:933\u201344. https:\/\/doi.org\/10.1161\/CIR.0b013e31820a55f5.","journal-title":"Heart Assoc Circ"},{"key":"21_CR56","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1161\/circresaha.118.312563","volume":"123","author":"AJ Donato","year":"2018","unstructured":"Donato AJ, Machin DR, Lesniewski LA. Mechanisms of dysfunction in the aging vasculature and role in age-related. Dis Circ Res. 2018;123:825\u201348. https:\/\/doi.org\/10.1161\/circresaha.118.312563.","journal-title":"Dis Circ Res"},{"key":"21_CR57","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1161\/01.cir.0000048893.62841.f7","volume":"107","author":"EG Lakatta","year":"2003","unstructured":"Lakatta EG, Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part II: the aging heart in health: links to heart disease. Circulation. 2003;107:346\u201354. https:\/\/doi.org\/10.1161\/01.cir.0000048893.62841.f7.","journal-title":"Circulation"},{"key":"21_CR58","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1016\/j.jacc.2017.01.064","volume":"69","author":"F Paneni","year":"2017","unstructured":"Paneni F, Diaz Ca\u00f1estro C, Libby P, L\u00fcscher TF, Camici GG. The aging cardiovascular system: understanding it at the cellular and clinical levels. J Am Coll Cardiol. 2017;69:1952\u201367. https:\/\/doi.org\/10.1016\/j.jacc.2017.01.064.","journal-title":"J Am Coll Cardiol"},{"key":"21_CR59","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1093\/eurheartj\/ehv140","volume":"36","author":"RD Spescha","year":"2015","unstructured":"Spescha RD, Klohs J, Semerano A, Giacalone G, Derungs RS, Reiner MF, et al. Post-ischaemic silencing of p66Shc reduces ischaemia\/reperfusion brain injury and its expression correlates to clinical outcome in stroke. Eur Heart J. 2015;36:1590\u2013600. https:\/\/doi.org\/10.1093\/eurheartj\/ehv140.","journal-title":"Eur Heart J"},{"key":"21_CR60","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1161\/circresaha.107.153692","volume":"101","author":"BC Capell","year":"2007","unstructured":"Capell BC, Collins FS, Nabel EG. Mechanisms of cardiovascular disease in accelerated aging syndromes. Circ Res. 2007;101:13\u201326. https:\/\/doi.org\/10.1161\/circresaha.107.153692.","journal-title":"Circ Res"},{"key":"21_CR61","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1161\/circresaha.111.246116","volume":"110","author":"J L\u00e4hteenvuo","year":"2012","unstructured":"L\u00e4hteenvuo J, Rosenzweig A. Effects of aging on angiogenesis. Circ Res. 2012;110:1252\u201364. https:\/\/doi.org\/10.1161\/circresaha.111.246116.","journal-title":"Circ Res"},{"issue":"1","key":"21_CR62","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1093\/cvr\/cvu016","volume":"102","author":"A Selathurai","year":"2014","unstructured":"Selathurai A, Deswaerte V, Kanellakis P, Tipping P, Toh BH, Bobik A, et al. Natural killer (NK) cells augment atherosclerosis by cytotoxic-dependent mechanisms. Cardiovasc Res. 2014;102(1):128\u201337. https:\/\/doi.org\/10.1093\/cvr\/cvu016.","journal-title":"Cardiovasc Res"},{"issue":"3","key":"21_CR63","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1006\/jaut.2000.0492","volume":"16","author":"D Fairweather","year":"2001","unstructured":"Fairweather D, Kaya Z, Shellam GR, Lawson CM, Rose NR. From infection to autoimmunity. J Autoimmun. 2001;16(3):175\u201386. https:\/\/doi.org\/10.1006\/jaut.2000.0492.","journal-title":"J Autoimmun"},{"issue":"3","key":"21_CR64","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.ajpath.2014.11.023","volume":"185","author":"S Ong","year":"2015","unstructured":"Ong S, Ligons DL, Barin JG, Wu L, Talor MV, Diny N, et al. Natural killer cells limit cardiac inflammation and fibrosis by halting eosinophil infiltration. Am J Pathol. 2015;185(3):847\u201361. https:\/\/doi.org\/10.1016\/j.ajpath.2014.11.023.","journal-title":"Am J Pathol"},{"key":"21_CR65","doi-asserted-by":"publisher","first-page":"2758","DOI":"10.1200\/jco.2008.20.8983","volume":"27","author":"BD Smith","year":"2009","unstructured":"Smith BD, Smith GL, Hurria A, Hortobagyi GN, Buchholz TA. Future of cancer incidence in the United States: burdens upon an aging changing nation. J Clin Oncol. 2009;27:2758\u201365. https:\/\/doi.org\/10.1200\/jco.2008.20.8983.","journal-title":"J Clin Oncol"},{"key":"21_CR66","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/s41568-019-0156-2","volume":"19","author":"DV Faget","year":"2019","unstructured":"Faget DV, Ren Q, Stewart SA. Unmasking senescence: context-dependent effects of SASP in cancer. Nat Rev Cancer. 2019;19:439\u201353. https:\/\/doi.org\/10.1038\/s41568-019-0156-2.","journal-title":"Nat Rev Cancer"},{"key":"21_CR67","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.2174\/092986710791299966","volume":"17","author":"Y Li","year":"2010","unstructured":"Li Y, Tollefsbol TO. Impact on DNA methylation in cancer prevention and therapy by bioactive dietary components. Curr Med Chem. 2010;17:2141\u201351. https:\/\/doi.org\/10.2174\/092986710791299966.","journal-title":"Curr Med Chem"},{"issue":"10","key":"21_CR68","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a026831","volume":"6","author":"Y Li","year":"2016","unstructured":"Li Y, Seto E. HDACs and HDAC inhibitors in cancer development and therapy. Cold Spring Harb Perspect Med. 2016;6(10):a026831. https:\/\/doi.org\/10.1101\/cshperspect.a026831.","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"2","key":"21_CR69","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20020454","volume":"20","author":"CL Lin","year":"2019","unstructured":"Lin CL, Tsai ML, Lin CY, Hsu KW, Hsieh WS, Chi WM, et al. HDAC1 and HDAC2 double knockout triggers cell apoptosis in advanced thyroid cancer. Int J Mol Sci. 2019;20(2):454. https:\/\/doi.org\/10.3390\/ijms20020454.","journal-title":"Int J Mol Sci"},{"key":"21_CR70","doi-asserted-by":"publisher","first-page":"22400","DOI":"10.1002\/jcp.28805","volume":"234","author":"S Ma","year":"2019","unstructured":"Ma S, Liu T, Xu L, Wang Y, Zhou J, Huang T, et al. Histone deacetylases inhibitor MS-275 suppresses human esophageal squamous cell carcinoma cell growth and progression via the PI3K\/Akt\/mTOR pathway. J Cell Physiol. 2019;234:22400\u201310. https:\/\/doi.org\/10.1002\/jcp.28805.","journal-title":"J Cell Physiol"},{"issue":"1","key":"21_CR71","doi-asserted-by":"publisher","DOI":"10.1186\/s40164-025-00633-8","volume":"14","author":"LV Jorgensen","year":"2025","unstructured":"Jorgensen LV, Christensen EB, Barnkob MB, Barington T. The clinical landscape of CAR NK cells. Exp Hematol Oncol. 2025;14(1):46. https:\/\/doi.org\/10.1186\/s40164-025-00633-8.","journal-title":"Exp Hematol Oncol"},{"issue":"3","key":"21_CR72","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1038\/s41591-023-02785-8","volume":"30","author":"D Marin","year":"2024","unstructured":"Marin D, Li Y, Basar R, Rafei H, Daher M, Dou J, et al. Safety, efficacy, and determinants of response of allogeneic CD19-specific CAR-NK cells in CD19\u2009+\u2009B cell tumors: a phase 1\/2 trial. Nat Med. 2024;30(3):772\u201384. https:\/\/doi.org\/10.1038\/s41591-023-02785-8.","journal-title":"Nat Med"},{"issue":"6","key":"21_CR73","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.jdiacomp.2019.03.007","volume":"33","author":"ME Al-Sofiani","year":"2019","unstructured":"Al-Sofiani ME, Ganji SS, Kalyani RR. Body composition changes in diabetes and aging. J Diabetes Complications. 2019;33(6):451\u20139. https:\/\/doi.org\/10.1016\/j.jdiacomp.2019.03.007.","journal-title":"J Diabetes Complications"},{"key":"21_CR74","doi-asserted-by":"publisher","unstructured":"Aguayo-Mazzucato C, van Haaren M, Mruk M, Lee TB Jr, Crawford C, Hollister-Lock J, et al. \u03b2 cell aging markers have heterogeneous distribution and are induced by insulin resistance. Cell Metab. 2017(4). https:\/\/doi.org\/10.1016\/j.cmet.2017.03.015.","DOI":"10.1016\/j.cmet.2017.03.015"},{"issue":"24","key":"21_CR75","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1001\/jama.2010.843","volume":"303","author":"ML Biggs","year":"2010","unstructured":"Biggs ML, Mukamal KL, Luchsinger JA, Ix JH, Carnethon MR, Anne B, Newman AB, et al. Association Between Adiposity in Midlife and Older Age and Risk of Diabetes in Older Adults. JAMA. 2010;303(24):2504\u201312. https:\/\/doi.org\/10.1001\/jama.2010.843.","journal-title":"JAMA"},{"issue":"2","key":"21_CR76","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1159\/000501745","volume":"66","author":"PK Fazeli","year":"2020","unstructured":"Fazeli PK, Lee H, Steinhauser ML. Aging is a powerful risk factor for type 2 diabetes mellitus independent of body mass index. Gerontology. 2020;66(2):209\u201310. https:\/\/doi.org\/10.1159\/000501745.","journal-title":"Gerontology"},{"issue":"4","key":"21_CR77","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0062418","volume":"8","author":"J Berrou","year":"2013","unstructured":"Berrou J, Fougeray S, Venot M, Chardiny V, Gautier JF, Dulphy N, et al. Natural killer cell function, an important target for infection and tumor protection, is impaired in type 2 diabetes. PLoS One. 2013;(4):e62418. https:\/\/doi.org\/10.1371\/journal.pone.0062418.","journal-title":"PLoS One"},{"key":"21_CR78","doi-asserted-by":"publisher","DOI":"10.15620\/cdc\/159281","volume":"508","author":"SD Emmerich","year":"2024","unstructured":"Emmerich SD, Fryar CD, Stierman B, Ogden CL. Obesity and severe obesity prevalence in adults: United States, August 2021-August 2023. NCHS Data Brief. 2024;508:10.15620\/cdc\/159281. https:\/\/doi.org\/10.15620\/cdc\/159281.","journal-title":"NCHS Data Brief"},{"key":"21_CR79","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/204164","volume":"2013","author":"K Sakuma","year":"2013","unstructured":"Sakuma K, Yamaguchi A. Sarcopenic obesity and endocrinal adaptation with age. Int J Endocrinol. 2013;2013:204164. https:\/\/doi.org\/10.1155\/2013\/204164.","journal-title":"Int J Endocrinol"},{"issue":"11","key":"21_CR80","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0260158","volume":"16","author":"SA Keramat","year":"2021","unstructured":"Keramat SA, Alam K, Rana RH, Chowdhury R, Farjana F, Hashmi R, et al. Obesity and the risk of developing chronic diseases in middle-aged and older adults: findings from an Australian longitudinal population survey, 2009\u20132017. PLoS One. 2021;(11):e0260158. https:\/\/doi.org\/10.1371\/journal.pone.0260158.","journal-title":"PLoS One"},{"issue":"1","key":"21_CR81","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0008660","volume":"5","author":"D O'Shea","year":"2010","unstructured":"O\u2019Shea D, Cawood TJ, O\u2019Farrelly C, Lynch L. Natural killer cells in obesity: impaired function and increased susceptibility to the effects of cigarette smoke. PLoS One. 2010;(1):e8660. https:\/\/doi.org\/10.1371\/journal.pone.0008660.","journal-title":"PLoS One"},{"issue":"12","key":"21_CR82","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1038\/s41590-018-0251-7","volume":"19","author":"X Michelet","year":"2018","unstructured":"Michelet X, Dyck L, Hogan A, Loftus RM, Duquette D, Wei K, et al. Metabolic reprogramming of natural killer cells in obesity limits antitumor responses. Nat Immunol. 2018;19(12):1330\u201340. https:\/\/doi.org\/10.1038\/s41590-018-0251-7.","journal-title":"Nat Immunol"},{"key":"21_CR83","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.clim.2016.01.007","volume":"177","author":"S Viel","year":"2017","unstructured":"Viel S, Besson L, Charrier E, Mar\u00e7ais A, Disse E, Bienvenu J, et al. Alteration of natural killer cell phenotype and function in obese individuals. Clin Immunol. 2017;177:12\u20137. https:\/\/doi.org\/10.1016\/j.clim.2016.01.007.","journal-title":"Clin Immunol"},{"key":"21_CR84","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2023.109744","volume":"255","author":"C De Barra","year":"2023","unstructured":"De Barra C, O\u2019Shea D, Hogan AE. NK cells vs. obesity: a tale of dysfunction & redemption. Clin Immunol. 2023;255:109744. https:\/\/doi.org\/10.1016\/j.clim.2023.109744.","journal-title":"Clin Immunol"},{"issue":"1","key":"21_CR85","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-019-0972-6","volume":"19","author":"P Golabi","year":"2019","unstructured":"Golabi P, Paik J, Reddy R, Bugianesi E, Trimble G, Younossi ZM. Prevalence and long-term outcomes of non-alcoholic fatty liver disease among elderly individuals from the United States. BMC Gastroenterol. 2019;19(1):56. https:\/\/doi.org\/10.1186\/s12876-019-0972-6.","journal-title":"BMC Gastroenterol"},{"key":"21_CR86","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/9018811","volume":"2022","author":"C Tang","year":"2022","unstructured":"Tang C, Chen H, Jiang L, Liu L. Liver regeneration: changes in oxidative stress, immune system, cytokines, and epigenetic modifications associated with aging. Oxid Med Cell Longev. 2022;2022:9018811. https:\/\/doi.org\/10.1155\/2022\/9018811.","journal-title":"Oxid Med Cell Longev"},{"issue":"6","key":"21_CR87","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10061161","volume":"10","author":"R Pais","year":"2021","unstructured":"Pais R, Maurel T. Natural history of NAFLD. J Clin Med. 2021;10(6):1161. https:\/\/doi.org\/10.3390\/jcm10061161.","journal-title":"J Clin Med"},{"issue":"3","key":"21_CR88","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/cmi.2015.96","volume":"13","author":"H Peng","year":"2016","unstructured":"Peng H, Wisse E, Tian Z. Liver natural killer cells: subsets and roles in liver immunity. Cell Mol Immunol. 2016;13(3):328\u201336. https:\/\/doi.org\/10.1038\/cmi.2015.96.","journal-title":"Cell Mol Immunol"},{"key":"21_CR89","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/1206737","volume":"2018","author":"P Liu","year":"2018","unstructured":"Liu P, Chen L, Zhang H. Natural killer cells in liver disease and hepatocellular carcinoma and the NK cell-based immunotherapy. J Immunol Res. 2018;2018:1206737. https:\/\/doi.org\/10.1155\/2018\/1206737.","journal-title":"J Immunol Res"},{"issue":"1","key":"21_CR90","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.jcmgh.2021.08.019","volume":"13","author":"F Wang","year":"2022","unstructured":"Wang F, Zhang X, Liu W, Zhou Y, Wei W, Liu D, et al. Activated natural killer cell promotes nonalcoholic steatohepatitis through mediating JAK\/STAT pathway. Cell Mol Gastroenterol Hepatol. 2022;13(1):257\u201374. https:\/\/doi.org\/10.1016\/j.jcmgh.2021.08.019.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"7","key":"21_CR91","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-06910-4","volume":"15","author":"M Gu","year":"2024","unstructured":"Gu M, Zhang Y, Lin Z, Hu X, Zhu Y, Xiao W, et al. Decrease in UCP1 by sustained high lipid promotes NK cell necroptosis to exacerbate nonalcoholic liver fibrosis. Cell Death Dis. 2024;15(7):518. https:\/\/doi.org\/10.1038\/s41419-024-06910-4.","journal-title":"Cell Death Dis"},{"key":"21_CR92","doi-asserted-by":"publisher","unstructured":"Guarente L, Sinclair DA, Kroemer G. Human trials exploring anti-aging medicines. Cell Metab. 2024;36(2):354\u2013376. doi: 10.1016\/j.cmet.2023.12.007. Anal Cell Pathol (Amst). 2018 Aug 2:2018:7871814. https:\/\/doi.org\/10.1155\/2018\/7871814","DOI":"10.1155\/2018\/7871814"},{"issue":"16","key":"21_CR93","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/nature08221","volume":"460","author":"DE Harrison","year":"2009","unstructured":"Harrison DE, Strong R, Sharp ZD, Nelson JF, Astle CM, Flurkey K, et al. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature. 2009;460(16):392\u20135. https:\/\/doi.org\/10.1038\/nature08221.","journal-title":"Nature"},{"issue":"7","key":"21_CR94","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2023.112166","volume":"176","author":"ZD Sharp","year":"2023","unstructured":"Sharp ZD, Strong R. Rapamycin, the only drug that consistently demonstrated to increase mammalian longevity. An update. Exp Gerontol. 2023;176(7):112166. https:\/\/doi.org\/10.1016\/j.exger.2023.112166.","journal-title":"Exp Gerontol"},{"key":"21_CR95","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/nature11861","volume":"493","author":"SC Johnson","year":"2013","unstructured":"Johnson SC, Rabinovitch PS, Kaeberlein M. mTOR is a key modulator of ageing and age-related disease. Nature. 2013;493:338\u201345. https:\/\/doi.org\/10.1038\/nature11861.","journal-title":"Nature"},{"key":"21_CR96","doi-asserted-by":"publisher","first-page":"4230","DOI":"10.4161\/cc.10.24.18486","volume":"10","author":"VN Anisimov","year":"2011","unstructured":"Anisimov VN, Zabezhinski MA, Popovich IG, Piskunova TS, Semenchenko AV, Tyndyk ML, et al. Rapamycin increases lifespan and inhibits spontaneous tumorigenesis in inbred female mice. Cell Cycle. 2011;10:4230\u20136. https:\/\/doi.org\/10.4161\/cc.10.24.18486.","journal-title":"Cell Cycle"},{"key":"21_CR97","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.2000559","volume":"2","author":"C Chen","year":"2009","unstructured":"Chen C, Liu Y, Liu Y, Zheng P. mTOR regulation and therapeutic rejuvenation of aging hematopoietic stem cells. Sci Signal. 2009;2:75. https:\/\/doi.org\/10.1126\/scisignal.2000559.","journal-title":"Sci Signal"},{"key":"21_CR98","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011272.pub2","volume":"7","author":"TH Sasongko","year":"2016","unstructured":"Sasongko TH, Ismail NF, Zabidi-Hussin Z. Rapamycin and rapalogs for tuberous sclerosis complex. Cochrane Database Syst Rev. 2016;7:011272. https:\/\/doi.org\/10.1002\/14651858.CD011272.pub2.","journal-title":"Cochrane Database Syst Rev"},{"key":"21_CR99","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1007\/s11357-019-00113-y","volume":"41","author":"CL Chung","year":"2019","unstructured":"Chung CL, Lawrence I, Hoffman M, Elgindi D, Nadhan K, Potnis M, et al. Topical rapamycin reduces markers of senescence and aging in human skin: an exploratory, prospective, randomized trial. GeroScience. 2019;41:861\u20139. https:\/\/doi.org\/10.1007\/s11357-019-00113-y.","journal-title":"GeroScience"},{"key":"21_CR100","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1093\/gerona\/glw090","volume":"71","author":"SI Arriola Apelo","year":"2016","unstructured":"Arriola Apelo SI, Lamming DW. Rapamycin: an inhibiTOR of aging emerges from the soil of Easter Island. J Gerontol A Biol Sci Med Sci. 2016;71:841\u20139. https:\/\/doi.org\/10.1093\/gerona\/glw090.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"21_CR101","doi-asserted-by":"publisher","DOI":"10.1111\/dme.14700","volume":"39","author":"C Newman","year":"2021","unstructured":"Newman C, Dunne FP. Metformin for pregnancy and beyond: the pros and cons. Diabet Med. 2021;39:e14700. https:\/\/doi.org\/10.1111\/dme.14700.","journal-title":"Diabet Med"},{"key":"21_CR102","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.tem.2019.07.015","volume":"30","author":"AA Soukas","year":"2019","unstructured":"Soukas AA, Hao H, Wu L. Metformin as anti-aging therapy: is it for everyone? Trends Endocrinol Metab. 2019;30:745\u201355. https:\/\/doi.org\/10.1016\/j.tem.2019.07.015.","journal-title":"Trends Endocrinol Metab"},{"key":"21_CR103","doi-asserted-by":"publisher","unstructured":"Pillai AA, Melo L, Frishman WH, Aronow WS. The Effects of Metformin on Weight Loss, Cardiovascular Health, and Longevity. Cardiol Rev. 2024;10\u20131097. https:\/\/doi.org\/10.1097\/CRD.0000000000000832.","DOI":"10.1097\/CRD.0000000000000832"},{"key":"21_CR104","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1507860","volume":"15","author":"Y Zhou","year":"2024","unstructured":"Zhou Y, Xue F. Revolutionary drug repositioning: the preventive and therapeutic potential of metformin and other antidiabetic drugs in age-related macular degeneration. Front Pharmacol. 2024;15:1507860. https:\/\/doi.org\/10.3389\/fphar.2024.1507860.","journal-title":"Front Pharmacol"},{"issue":"4","key":"21_CR105","doi-asserted-by":"publisher","DOI":"10.3390\/molecules30040816","volume":"30","author":"T Zhang","year":"2025","unstructured":"Zhang T, Zhou L, Makarczyk MJ, Feng P, Zhang J. The anti-aging mechanism of metformin: from molecular insights to clinical applications. Molecules. 2025;30(4):816. https:\/\/doi.org\/10.3390\/molecules30040816.","journal-title":"Molecules"},{"key":"21_CR106","doi-asserted-by":"publisher","DOI":"10.1007\/s10522-024-10156-0","volume":"26","author":"YV Nikitchenko","year":"2024","unstructured":"Nikitchenko YV, Klochkov VK, Kavok NS, Karpenko NA, Yefimova SL, Semynozhenko VP, et al. Geroprotective effects of GdVO(4):Eu(3 +) nanoparticles, metformin and calorie restriction in male rats with accelerated aging induced by overnutrition in early postnatal ontogenesis. Biogerontology. 2024;26:14. https:\/\/doi.org\/10.1007\/s10522-024-10156-0.","journal-title":"Biogerontology"},{"key":"21_CR107","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13488","volume":"21","author":"B Onken","year":"2022","unstructured":"Onken B, Sedore CA, Coleman-Hulbert AL, Hall D, Johnson E, Jones EG, et al. Metformin treatment of diverse Caenorhabditis species reveals the importance of genetic background in longevity and healthspan extension outcomes. Aging Cell. 2022;21:e13488. https:\/\/doi.org\/10.1111\/acel.13488.","journal-title":"Aging Cell"},{"key":"21_CR108","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.fct.2013.03.038","volume":"61","author":"KM Kasiotis","year":"2013","unstructured":"Kasiotis KM, Pratsinis H, Kletsas D, Haroutounian SA. Resveratrol and related stilbenes: their anti-aging and anti-angiogenic properties. Food Chem Toxicol. 2013;61:112\u201320. https:\/\/doi.org\/10.1016\/j.fct.2013.03.038.","journal-title":"Food Chem Toxicol"},{"issue":"1","key":"21_CR109","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/9932218","volume":"2021","author":"DD Zhou","year":"2021","unstructured":"Zhou DD, Luo M, Huang SY, Saimaiti A, Shang A, Gan RY, et al. Effects and mechanisms of resveratrol on aging and age-related diseases. Oxid Med Cell Longev. 2021;2021(1):9932218. https:\/\/doi.org\/10.1155\/2021\/9932218.","journal-title":"Oxid Med Cell Longev"},{"issue":"3","key":"21_CR110","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.cmet.2017.11.002","volume":"27","author":"J Yoshino","year":"2018","unstructured":"Yoshino J, Baur JA, Imai SI. NAD+ intermediates: the biology and therapeutic potential of NMN and NR. Cell Metab. 2018;27(3):513\u201328. https:\/\/doi.org\/10.1016\/j.cmet.2017.11.002.","journal-title":"Cell Metab"},{"issue":"6158","key":"21_CR111","doi-asserted-by":"publisher","DOI":"10.1126\/science.1243417","volume":"342","author":"CB Peek","year":"2013","unstructured":"Peek CB, Affinati AH, Ramsey KM, Kuo HY, Yu W, Sena LA, et al. Circadian clock NAD+ cycle drives mitochondrial oxidative metabolism in mice. Science. 2013;342(6158):1243417. https:\/\/doi.org\/10.1126\/science.1243417.","journal-title":"Science"},{"key":"21_CR112","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.jare.2021.08.003","volume":"37","author":"H Nadeeshani","year":"2021","unstructured":"Nadeeshani H, Li J, Ying T, Zhang B, Lu J. Nicotinamide mononucleotide (NMN) as an anti-aging health product - promises and safety concerns. J Adv Res. 2021;37:267\u201378. https:\/\/doi.org\/10.1016\/j.jare.2021.08.003.","journal-title":"J Adv Res"},{"issue":"6","key":"21_CR113","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.cmet.2016.09.013","volume":"24","author":"KF Mills","year":"2016","unstructured":"Mills KF, Yoshida S, Stein LR, Grozio A, Kubota S, Sasaki Y, et al. Long-term administration of nicotinamide mononucleotide mitigates age-associated physiological decline in mice. Cell Metab. 2016;24(6):795\u2013806. https:\/\/doi.org\/10.1016\/j.cmet.2016.09.013.","journal-title":"Cell Metab"},{"issue":"2","key":"21_CR114","doi-asserted-by":"publisher","DOI":"10.1136\/openhrt-2022-002171","volume":"9","author":"JJ DiNicolantonio","year":"2022","unstructured":"DiNicolantonio JJ, McCarty MF, O\u2019Keefe JH. Nutraceutical activation of Sirt1: a review. Open Heart. 2022;9(2):e002171. https:\/\/doi.org\/10.1136\/openhrt-2022-002171.","journal-title":"Open Heart"},{"key":"21_CR115","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2021.101410","volume":"70","author":"S Borgoni","year":"2021","unstructured":"Borgoni S, Kudryashova KS, Burka K, de Magalh\u00e3es JP. Targeting immune dysfunction in aging. Ageing Res Rev. 2021;70:101410. https:\/\/doi.org\/10.1016\/j.arr.2021.101410.","journal-title":"Ageing Res Rev"},{"issue":"7372","key":"21_CR116","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/nature10600","volume":"479","author":"DJ Baker","year":"2011","unstructured":"Baker DJ, Wijshake T, Tchkonia T, LeBrasseur NK, Childs BG, van de Sluis B, et al. Clearance of p16Ink4a-positive senescent cells delays ageingassociated disorders. Nature. 2011;479(7372):232\u20136. https:\/\/doi.org\/10.1038\/nature10600.","journal-title":"Nature"},{"issue":"7589","key":"21_CR117","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/nature16932","volume":"530","author":"DJ Baker","year":"2016","unstructured":"Baker DJ, Childs BG, Durik M, Wijers ME, Sieben CJ, Zhong J, et al. Naturally occurring p16(Ink4a)-positive cells shorten healthy lifespan. Nature. 2016;530(7589):184\u20139. https:\/\/doi.org\/10.1038\/nature16932.","journal-title":"Nature"},{"issue":"3","key":"21_CR118","doi-asserted-by":"publisher","DOI":"10.3390\/cells9030671","volume":"9","author":"P Song","year":"2020","unstructured":"Song P, An J, Zou MH. Immune clearance of senescent cells to combat ageing and chronic diseases. Cells. 2020;9(3):671. https:\/\/doi.org\/10.3390\/cells9030671.","journal-title":"Cells"},{"issue":"15","key":"21_CR119","doi-asserted-by":"publisher","first-page":"2629","DOI":"10.1016\/j.jmb.2019.05.036","volume":"431","author":"A Soto-Gamez","year":"2019","unstructured":"Soto-Gamez A, Quax WJ, Demaria M. Regulation of survival networks in senescent cells: from mechanisms to interventions. J Mol Biol. 2019;431(15):2629\u201343. https:\/\/doi.org\/10.1016\/j.jmb.2019.05.036.","journal-title":"J Mol Biol"},{"issue":"5","key":"21_CR120","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1111\/joim.13141","volume":"288","author":"JL Kirkland","year":"2020","unstructured":"Kirkland JL, Tchkonia T. Senolytic drugs: from discovery to translation. J Intern Med. 2020;288(5):518\u201336. https:\/\/doi.org\/10.1111\/joim.13141.","journal-title":"J Intern Med"},{"issue":"6526","key":"21_CR121","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1126\/science.abb5916","volume":"371","author":"Y Johmura","year":"2021","unstructured":"Johmura Y, Yamanaka T, Omori S, Wang TW, Sugiura Y, Matsumoto M, et al. Senolysis by glutaminolysis inhibition ameliorates various age-associated disorders. Science. 2021;371(6526):265\u201370. https:\/\/doi.org\/10.1126\/science.abb5916.","journal-title":"Science"},{"key":"21_CR122","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.ebiom.2019.08.069","volume":"47","author":"LJ Hickson","year":"2019","unstructured":"Hickson LJ, Langhi Prata LGP, Bobart SA, Evans TK, Giorgadze N, Hashmi SK, et al. Senolytics decrease senescent cells in humans: preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease. EBioMedicine. 2019;47:446\u201356. https:\/\/doi.org\/10.1016\/j.ebiom.2019.08.069.","journal-title":"EBioMedicine"},{"issue":"6","key":"21_CR123","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1002\/JLB.MR0718-299R","volume":"105","author":"F Antonangeli","year":"2019","unstructured":"Antonangeli F, Zingoni A, Soriani A, Santoni A. Senescent cells: living or dying is a matter of NK cells. J Leukoc Biol. 2019;105(6):1275\u201383. https:\/\/doi.org\/10.1002\/JLB.MR0718-299R.","journal-title":"J Leukoc Biol"},{"key":"21_CR124","doi-asserted-by":"publisher","first-page":"328","DOI":"10.18632\/aging.100897","volume":"8","author":"A Sagiv","year":"2016","unstructured":"Sagiv A, Burton DG, Moshayev Z, Vadai E, Wensveen F, Ben-Dor S, et al. NKG2D ligands mediate immunosurveillance of senescent cells. Aging. 2016;8:328\u201344. https:\/\/doi.org\/10.18632\/aging.100897.","journal-title":"Aging"},{"key":"21_CR125","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrep.2022.101380","volume":"32","author":"N Chelyapov","year":"2022","unstructured":"Chelyapov N, Nguyen TT, Gonzalez R. Autologous NK cells propagated and activated ex vivo decrease senescence markers in human PBMCs. Biochem Biophys Rep. 2022;32:101380. https:\/\/doi.org\/10.1016\/j.bbrep.2022.101380.","journal-title":"Biochem Biophys Rep"},{"issue":"4","key":"21_CR126","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-04562-w","volume":"13","author":"Z Bai","year":"2022","unstructured":"Bai Z, Yang P, Yu F, Li Z, Yao Z, Martinez J, et al. Combining adoptive NK cell infusion with a dopamine-releasing peptide reduces senescent cells in aged mice. Cell Death Dis. 2022;13(4):305. https:\/\/doi.org\/10.1038\/s41419-022-04562-w.","journal-title":"Cell Death Dis"},{"key":"21_CR127","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.940577","volume":"13","author":"X Tang","year":"2022","unstructured":"Tang X, Deng B, Zang A, He X, Zhou Y, Wang D, et al. Characterization of age-related immune features after autologous NK cell infusion: protocol for an open-label and randomized controlled trial. Front Immunol. 2022;13:940577. https:\/\/doi.org\/10.3389\/fimmu.2022.940577.","journal-title":"Front Immunol"},{"issue":"3","key":"21_CR128","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1182\/blood-2007-09-077438","volume":"112","author":"MA Caligiuri","year":"2008","unstructured":"Caligiuri MA. Human natural killer cells. Blood. 2008;112(3):461\u20139. https:\/\/doi.org\/10.1182\/blood-2007-09-077438.","journal-title":"Blood"},{"issue":"1","key":"21_CR129","doi-asserted-by":"publisher","DOI":"10.1186\/s12979-020-00187-9","volume":"17","author":"A Kale","year":"2020","unstructured":"Kale A, Sharma A, Stolzing A, Desprez PY, Campisi J. Role of immune cells in the removal of deleterious senescent cells. Immun Ageing. 2020;17(1):16. https:\/\/doi.org\/10.1186\/s12979-020-00187-9.","journal-title":"Immun Ageing"},{"issue":"19","key":"21_CR130","doi-asserted-by":"publisher","first-page":"3865","DOI":"10.1182\/blood-2010-04-282301","volume":"116","author":"S Lopez-Verg\u00e8s","year":"2010","unstructured":"Lopez-Verg\u00e8s S, Milush JM, Pandey S, York VA, Arakawa-Hoyt J, Pircher H, et al. CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16\u2009+\u2009NK-cell subset. Blood. 2010;116(19):3865\u201374.","journal-title":"Blood"},{"issue":"36","key":"21_CR131","doi-asserted-by":"publisher","first-page":"14725","DOI":"10.1073\/pnas.1110900108","volume":"108","author":"S Lopez-Verg\u00e8s","year":"2011","unstructured":"Lopez-Verg\u00e8s S, Milush JM, Schwartz BS, Pando MJ, Jarjoura J, York VA, et al. Expansion of a unique CD57\u2009+\u2009NKG2Chi natural killer cell subset during acute human cytomegalovirus infection. Proc Natl Acad Sci U S A. 2011;108(36):14725\u201332.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"21_CR132","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00909","volume":"10","author":"AD Barrow","year":"2019","unstructured":"Barrow AD, Martin CJ, Colonna M. The natural cytotoxicity receptors in health and disease. Front Immunol. 2019;10(7):909.","journal-title":"Front Immunol"},{"key":"21_CR133","doi-asserted-by":"publisher","first-page":"3185","DOI":"10.18632\/aging.101078","volume":"8","author":"C Borras","year":"2016","unstructured":"Borras C, Abdelaziz KM, Gambini J, Serna E, Ingl\u00e9s M, de la Fuente M, et al. Human exceptional longevity: transcriptome from centenarians is distinct from septuagenarians and reveals a role of Bcl-xL in successful aging. Aging Albany NY. 2016;8:3185\u2013208. https:\/\/doi.org\/10.18632\/aging.101078.","journal-title":"Aging Albany NY"},{"issue":"2","key":"21_CR134","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1101\/gad.235184.113","volume":"28","author":"R Salama","year":"2014","unstructured":"Salama R, Sadaie M, Hoare M, Narita M. Cellular senescence and its effector programs. Genes Dev. 2014;28(2):99\u2013114. https:\/\/doi.org\/10.1101\/gad.235184.113.","journal-title":"Genes Dev"},{"key":"21_CR135","doi-asserted-by":"publisher","unstructured":"Verhezen T, Wouters A, Smits E, De Waele J. Powering immunity: mitochondrial dynamics in natural killer cells. Trends Mol Med. 2025 May 19:S1471-4914(25)00106-6. https:\/\/doi.org\/10.1016\/j.molmed.2025.04.004","DOI":"10.1016\/j.molmed.2025.04.004"},{"issue":"1","key":"21_CR136","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-06939-5","volume":"15","author":"X An","year":"2024","unstructured":"An X, Yu W, Liu J, Tang D, Yang L, Chen X. Oxidative cell death in cancer: mechanisms and therapeutic opportunities. Cell Death Dis. 2024;15(1):556. https:\/\/doi.org\/10.1038\/s41419-024-06939-5.","journal-title":"Cell Death Dis"},{"issue":"19","key":"21_CR137","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2020.00231","volume":"10","author":"S Pierce","year":"2020","unstructured":"Pierce S, Geanes ES, Bradley T. Targeting natural killer cells for improved immunity and control of the adaptive immune response. Front Cell Infect Microbiol. 2020;10(19):231. https:\/\/doi.org\/10.3389\/fcimb.2020.00231.","journal-title":"Front Cell Infect Microbiol"},{"key":"21_CR138","doi-asserted-by":"publisher","DOI":"10.3390\/cells10030708","volume":"10","author":"E Feng","year":"2021","unstructured":"Feng E, Balint E, Poznanski SM, Ashkar AA, Loeb M. Aging and interferons: impacts on inflammation and viral disease outcomes. Cells. 2021;10:708. https:\/\/doi.org\/10.3390\/cells10030708.","journal-title":"Cells"},{"issue":"12","key":"21_CR139","doi-asserted-by":"publisher","first-page":"6577","DOI":"10.3390\/ijms23126577","volume":"23","author":"S Garcinu\u00f1o","year":"2022","unstructured":"Garcinu\u00f1o S, Gil-Etayo FJ, Mancebo E, L\u00f3pez-Nevado M, Lalueza A, D\u00edaz-Sim\u00f3n R, et al. Effective natural killer cell degranulation is an essential key in COVID-19 evolution. Int J Mol Sci. 2022;23(12):6577. https:\/\/doi.org\/10.3390\/ijms23126577.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"21_CR140","doi-asserted-by":"publisher","first-page":"2410","DOI":"10.1182\/blood.V92.7.2410","volume":"92","author":"D Rukavina","year":"1998","unstructured":"Rukavina D, Laskarin G, Rubesa G, Strbo N, Bedenicki I, Manestar D, Glavas M, Christmas SE, Podack ER. Age-related decline of perforin expression in human cytotoxic T lymphocytes and natural killer cells. Blood. 1998;92(7):2410\u201320.","journal-title":"Blood"},{"issue":"13","key":"21_CR141","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01124","volume":"8","author":"S Paul","year":"2017","unstructured":"Paul S, Lal G. The molecular mechanism of natural killer cells function and its importance in cancer immunotherapy. Front Immunol. 2017;8(13):1124. https:\/\/doi.org\/10.3389\/fimmu.2017.01124.","journal-title":"Front Immunol"},{"issue":"2","key":"21_CR142","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.immuni.2016.07.013","volume":"45","author":"S Chen","year":"2016","unstructured":"Chen S, Yang M, Du J, Li D, Li Z, Cai C, et al. The self-specific activation receptor SLAM family is critical for NK cell education. Immunity. 2016;45(2):292\u2013304. https:\/\/doi.org\/10.1016\/j.immuni.2016.07.013.","journal-title":"Immunity"},{"issue":"17","key":"21_CR143","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2023216118","volume":"118","author":"Z Huang","year":"2021","unstructured":"Huang Z, Chen B, Liu X, Li H, Xie L, Gao Y, et al. Effects of sex and aging on the immune cell landscape as assessed by single-cell transcriptomic analysis. Proc Natl Acad Sci U S A. 2021;118(17):e2023216118. https:\/\/doi.org\/10.1073\/pnas.2023216118.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"21_CR144","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/195956","volume":"2012","author":"X Camous","year":"2012","unstructured":"Camous X, Pera A, Solana R, Larbi A. NK cells in healthy aging and age-associated diseases. J Biomed Biotechnol. 2012;2012:195956. https:\/\/doi.org\/10.1155\/2012\/195956.","journal-title":"J Biomed Biotechnol"},{"key":"21_CR145","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/3128758","volume":"2018","author":"C Solana","year":"2018","unstructured":"Solana C, Tarazona R, Solana R. Immunosenescence of natural killer cells, inflammation, and Alzheimer\u2019s disease. Int J Alzheimers Dis. 2018;2018:3128758. https:\/\/doi.org\/10.1155\/2018\/3128758.","journal-title":"Int J Alzheimers Dis"},{"issue":"12","key":"21_CR146","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1038\/nm.4000","volume":"21","author":"BG Childs","year":"2015","unstructured":"Childs BG, Durik M, Baker DJ, van Deursen JM. Cellular senescence in aging and age-related disease: from mechanisms to therapy. Nat Med. 2015;21(12):1424\u201335. https:\/\/doi.org\/10.1038\/nm.4000.","journal-title":"Nat Med"},{"key":"21_CR147","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2024.102540","volume":"101","author":"A Ajoolabady","year":"2024","unstructured":"Ajoolabady A, Pratico D, Tang D, Zhou S, Franceschi C, Ren J. Immunosenescence and inflammaging: mechanisms and role in diseases. Ageing Res Rev. 2024;101:102540. https:\/\/doi.org\/10.1016\/j.arr.2024.102540.","journal-title":"Ageing Res Rev"},{"issue":"9","key":"21_CR148","doi-asserted-by":"publisher","first-page":"102264","DOI":"10.1016\/j.xcrm.2025.102264","volume":"6","author":"L Spray","year":"2025","unstructured":"Spray L, Richardson G, Haendeler J, Altschmied J, Rumampouw V, Wallis SB, et al. Cardiovascular inflammaging: Mechanisms, consequences, and therapeutic perspectives. Cell Rep Med. 2025;6(9):102264. https:\/\/doi.org\/10.1016\/j.xcrm.2025.102264.","journal-title":"Cell Rep Med"},{"issue":"9","key":"21_CR149","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.3390\/brainsci12091237","volume":"12","author":"AM Kosyreva","year":"2022","unstructured":"Kosyreva AM, Sentyabreva AV, Tsvetkov IS, Makarova OV. Alzheimer\u2019s Disease and Inflammaging. Brain Sci. 2022;12(9):1237. https:\/\/doi.org\/10.3390\/brainsci12091237.","journal-title":"Brain Sci"},{"issue":"4","key":"21_CR150","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3390\/nu7042589","volume":"7","author":"R Ostan","year":"2015","unstructured":"Ostan R, Lanzarini C, Pini E, Scurti M, Vianello D, Bertarelli C, et al. Inflammaging and cancer: a challenge for the Mediterranean diet. Nutrients. 2015;7(4):9\u2013621. https:\/\/doi.org\/10.3390\/nu7042589.","journal-title":"Nutrients"},{"key":"21_CR151","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2023.106156","volume":"183","author":"C Qi","year":"2023","unstructured":"Qi C, Liu Q. Natural killer cells in aging and age-related diseases. Neurobiol Dis. 2023;183:106156. https:\/\/doi.org\/10.1016\/j.nbd.2023.106156.","journal-title":"Neurobiol Dis"},{"key":"21_CR152","doi-asserted-by":"publisher","first-page":"4042","DOI":"10.1172\/JCI90387","volume":"127","author":"JA Wagner","year":"2017","unstructured":"Wagner JA, Rosario M, Romee R, Berrien-Elliott MM, Schneider SE, Leong JW, et al. CD56bright NK cells exhibit potent antitumor responses following IL-15 priming. J Clin Invest. 2017;127:4042\u201358. https:\/\/doi.org\/10.1172\/JCI90387.","journal-title":"J Clin Invest"},{"key":"21_CR153","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/ni.2936","volume":"15","author":"A Mar\u00e7ais","year":"2014","unstructured":"Mar\u00e7ais A, Cherfils-Vicini J, Viant C, Degouve S, Viel S, Fenis A, et al. The metabolic checkpoint kinase mTOR is essential for IL-15 signaling during the development and activation of NK cells. Nat Immunol. 2014;15:749\u201357. https:\/\/doi.org\/10.1038\/ni.2936.","journal-title":"Nat Immunol"},{"key":"21_CR154","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1182\/blood-2016-02-698027","volume":"128","author":"Y Mao","year":"2016","unstructured":"Mao Y, van Hoef V, Zhang X, Wennerberg E, Lorent J, Witt K, et al. IL-15 activates mTOR and primes stress-activated gene expression leading to prolonged antitumor capacity of NK cells. Blood. 2016;128:1475\u201389. https:\/\/doi.org\/10.1182\/blood-2016-02-698027.","journal-title":"Blood"},{"key":"21_CR155","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.4049\/jimmunol.168.3.1146","volume":"168","author":"M Nakahira","year":"2002","unstructured":"Nakahira M, Ahn HJ, Park WR, Gao P, Tomura M, Park CS, et al. Synergy of IL-12 and IL-18 for IFN-gamma gene expression: IL-12-induced STAT4 contributes to IFN-gamma promoter activation by up-regulating the binding activity of IL-18-induced activator protein 1. J Immunol. 2002;168:1146\u201353. https:\/\/doi.org\/10.4049\/jimmunol.168.3.1146.","journal-title":"J Immunol"},{"issue":"12","key":"21_CR156","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12123586","volume":"12","author":"Y Yang","year":"2020","unstructured":"Yang Y, Lundqvist A. Immunomodulatory effects of IL-2 and IL-15; implications for cancer immunotherapy. Cancers (Basel). 2020;12(12):3586. https:\/\/doi.org\/10.3390\/cancers12123586.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"21_CR157","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-025-01681-2","volume":"17","author":"CH Z\u00fa\u00f1iga","year":"2025","unstructured":"Z\u00fa\u00f1iga CH, Acosta BI, Menchaca R, Amescua CA, Hong S, Hui L, et al. Treatment of Alzheimer\u2019s disease subjects with expanded non-genetically modified autologous natural killer cells (SNK01): a phase I study. Alzheimers Res Ther. 2025;17(1):40. https:\/\/doi.org\/10.1186\/s13195-025-01681-2.","journal-title":"Alzheimers Res Ther"},{"issue":"22","key":"21_CR158","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14225657","volume":"14","author":"J Xiao","year":"2022","unstructured":"Xiao J, Zhang T, Gao F, Zhou Z, Shu G, Zou Y, et al. Natural killer cells: a promising kit in the adoptive cell therapy toolbox. Cancers (Basel). 2022;14(22):5657. https:\/\/doi.org\/10.3390\/cancers14225657.","journal-title":"Cancers (Basel)"},{"issue":"709","key":"21_CR159","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.add1951","volume":"15","author":"D Yang","year":"2023","unstructured":"Yang D, Sun B, Li S, Wei W, Liu X, Cui X, et al. NKG2D-CAR T cells eliminate senescent cells in aged mice and nonhuman primates. Sci Transl Med. 2023;15(709):eadd1951. https:\/\/doi.org\/10.1126\/scitranslmed.add1951.","journal-title":"Sci Transl Med"},{"issue":"2","key":"21_CR160","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/imm.13094","volume":"158","author":"LO Afolabi","year":"2019","unstructured":"Afolabi LO, Adeshakin AO, Sani MM, Bi J, Wan X. Genetic reprogramming for NK cell cancer immunotherapy with CRISPR\/Cas9. Immunology. 2019;158(2):63\u20139. https:\/\/doi.org\/10.1111\/imm.13094.","journal-title":"Immunology"},{"issue":"4","key":"21_CR161","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s00262-015-1750-0","volume":"65","author":"AR Manser","year":"2016","unstructured":"Manser AR, Uhrberg M. Age-related changes in natural killer cell repertoires: impact on NK cell function and immune surveillance. Cancer Immunol Immunother. 2016;65(4):417\u201326. https:\/\/doi.org\/10.1007\/s00262-015-1750-0.","journal-title":"Cancer Immunol Immunother"},{"key":"21_CR162","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/7871814","volume":"2018","author":"SS Gounder","year":"2018","unstructured":"Gounder SS, Abdullah BJJ, Radzuanb NEIBM, Zain FDBM, Sait NBM, Chua C, et al. Effect of aging on NK cell population and their proliferation at ex vivo culture condition. Anal Cell Pathol (Amst). 2018;2018:7871814. https:\/\/doi.org\/10.1155\/2018\/7871814.","journal-title":"Anal Cell Pathol (Amst)"},{"issue":"4","key":"21_CR163","doi-asserted-by":"publisher","first-page":"253.e1","DOI":"10.1016\/j.jtct.2022.12.025","volume":"29","author":"DH Yoon","year":"2023","unstructured":"Yoon DH, Koh Y, Jung M, Kwak JE, Shin EC, Hwang YK, et al. Phase I study: safety and efficacy of an ex vivo-expanded allogeneic natural killer cell (MG4101) with rituximab for relapsed\/refractory B cell non-Hodgkin lymphoma. Transplantation and Cellular Therapy. 2023;29(4):253.e1-253.e9. https:\/\/doi.org\/10.1016\/j.jtct.2022.12.025.","journal-title":"Transplantation and Cellular Therapy"},{"issue":"4","key":"21_CR164","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/s41423-021-00808-3","volume":"19","author":"F Fang","year":"2022","unstructured":"Fang F, Xie S, Chen M, Li Y, Yue J, Ma J, et al. Advances in NK cell production. Cell Mol Immunol. 2022;19(4):460\u201381. https:\/\/doi.org\/10.1038\/s41423-021-00808-3.","journal-title":"Cell Mol Immunol"},{"key":"21_CR165","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.molmed.2020.03.005","volume":"26","author":"RJ Pignolo","year":"2020","unstructured":"Pignolo RJ, Passos JF, Khosla S, Tchkonia T, Kirkland JL. Reducing senescent cell burden in aging and disease. Trends Mol Med. 2020;26:630\u20138. https:\/\/doi.org\/10.1016\/j.molmed.2020.03.005.","journal-title":"Trends Mol Med"},{"key":"21_CR166","unstructured":"Li L, Raitman I, Rousseva V, Kang L, Kilcoyne A, Hariri R et al. Human placental hematopoietic stem cell derived natural killer cells preferentially eliminate senescent cells derived from A tumor model. Molecular Therapy. 2024;32(4):643-4."},{"issue":"6","key":"21_CR167","doi-asserted-by":"publisher","first-page":"907","DOI":"10.4062\/biomolther.2025.153","volume":"33","author":"S Moon","year":"2025","unstructured":"Moon S, Song K. CAR-based cell and gene therapies: global clinical landscape and emerging therapeutic strategies from ClinicalTrials.gov. Biomol Ther (Seoul). 2025;33(6):907\u201323. https:\/\/doi.org\/10.4062\/biomolther.2025.153.","journal-title":"Biomol Ther (Seoul)"},{"key":"21_CR168","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.732135","volume":"12","author":"EL Heipertz","year":"2021","unstructured":"Heipertz EL, Zynda ER, Stav-Noraas TE, et al. Current perspectives on \u201coff-the-shelf\u201d allogeneic NK and CAR-NK cell therapies. Front Immunol. 2021;12:732135. https:\/\/doi.org\/10.3389\/fimmu.2021.732135.","journal-title":"Front Immunol"},{"issue":"3","key":"21_CR169","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1093\/stcltm\/szad087","volume":"13","author":"A Maia","year":"2024","unstructured":"Maia A, Tarannum M, Rome R. Genetic manipulation approaches to enhance the clinical application of NK cell-based immunotherapy. Stem Cells Transl Med. 2024;13(3):230\u201342. https:\/\/doi.org\/10.1093\/stcltm\/szad087.","journal-title":"Stem Cells Transl Med"},{"issue":"2","key":"21_CR170","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1038\/leu.2017.226.","volume":"32","author":"E Liu","year":"2018","unstructured":"Liu E, Tong Y, Dotti G, Shaim H, Savoldo B, Mukherjee M, et al. Cord blood NK cells engineered to express IL-15 and a CD19-targeted CAR show long-term persistence and potent antitumor activity. Leukemia. 2018;32(2):520\u201331. https:\/\/doi.org\/10.1038\/leu.2017.226.","journal-title":"Leukemia"},{"issue":"6","key":"21_CR171","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1038\/leu.2010.75.","volume":"24","author":"V Hoyos","year":"2010","unstructured":"Hoyos V, Savoldo B, Quintarelli C, Mahendravada A, Zhang M, Vera J, et al. Engineering CD19-specific T lymphocytes with interleukin-15 and a suicide gene to enhance their anti-lymphoma\/leukemia effects and safety. Leukemia. 2010;24(6):1160\u201370. https:\/\/doi.org\/10.1038\/leu.2010.75.","journal-title":"Leukemia"},{"issue":"4","key":"21_CR172","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/s1074-7613(00)80246-0.","volume":"4","author":"Y Tagaya","year":"1996","unstructured":"Tagaya Y, Bamford RN, DeFilippis AP, Waldmann TA. IL-15: a pleiotropic cytokine with diverse receptor\/signaling pathways whose expression is controlled at multiple levels. Immunity. 1996;4(4):329\u201336. https:\/\/doi.org\/10.1016\/s1074-7613(00)80246-0.","journal-title":"Immunity"},{"key":"21_CR173","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1056\/NEJMoa1910607.","volume":"382","author":"E Liu","year":"2020","unstructured":"Liu E, Marin D, Banerjee P, Macapinlac HA, Thompson P, Basar R, et al. Use of CAR-transduced natural killer cells in CD19-positive lymphoid tumors. N Engl J Med. 2020;382:545\u201353. https:\/\/doi.org\/10.1056\/NEJMoa1910607.","journal-title":"N Engl J Med"},{"key":"21_CR174","doi-asserted-by":"publisher","unstructured":"Xiong Q, Zhang H, Ji X, Zhang Y, Shi G, Dai L et al. A novel membrane-bound interleukin-2 promotes NK-92 cell persistence and anti-tumor activity.Oncoimmunology. 2022;11(1):2127282. https:\/\/doi.org\/10.1080\/2162402X.2022.2127282.","DOI":"10.1080\/2162402X.2022.2127282"},{"key":"21_CR175","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.886429.","volume":"13","author":"F Rossi","year":"2022","unstructured":"Rossi F, Fredericks N, Snowden A, Allegrezza MJ, Moreno-Nieves UY. Next generation natural killer cells for cancer immunotherapy. Front Immunol. 2022;13:886429. https:\/\/doi.org\/10.3389\/fimmu.2022.886429.","journal-title":"Front Immunol"},{"key":"21_CR176","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1182\/BLOOD.V71.4.1113.1113.","volume":"71","author":"R Mollicone","year":"1988","unstructured":"Mollicone R, Caillard T, le Pendu J, Francois A, Sansonetti N, Villarroya H, et al. Expression of ABH and X (Lex) antigens on platelets and lymphocytes. Blood. 1988;71:1113\u20139. https:\/\/doi.org\/10.1182\/BLOOD.V71.4.1113.1113.","journal-title":"Blood"},{"key":"21_CR177","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/s41577-019-0200-1","volume":"19","author":"R Lanza","year":"2019","unstructured":"Lanza R, Russell DW, Nagy A. Engineering Universal Cells That Evade Immune Detection. Nat Rev Immunol 2019. 2019;19:12. https:\/\/doi.org\/10.1038\/s41577-019-0200-1.","journal-title":"Nat Rev Immunol 2019"},{"key":"21_CR178","doi-asserted-by":"publisher","first-page":"586168","DOI":"10.3389\/FIMMU.2020.586168","volume":"11","author":"K Hoerster","year":"2021","unstructured":"Hoerster K, Uhrberg M, Wiek C, Horn PA, Hanenberg H, Heinrichs S. HLA Class I Knockout Converts Allogeneic Primary NK Cells Into Suitable Effectors for Off-The-Shelf. Immunotherapy Front Immunol. 2021;11:586168. https:\/\/doi.org\/10.3389\/FIMMU.2020.586168.","journal-title":"Immunotherapy Front Immunol"},{"key":"21_CR179","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1002\/EJI.200424913","volume":"34","author":"L \u00d6berg","year":"2004","unstructured":"\u00d6berg L, Johansson S, Micha\u00eblsson J, Tomasello E, Vivier E, K\u00e4rre K, et al. Loss or Mismatch of MHC Class\u2004I is Sufficient to Trigger NK Cell-Mediated Rejection of Resting Lymphocytes In Vivo \u2013 Role of KARAP\/DAP12-Dependent and -Independent Pathways. Eur J Immunol. 2004;34:1646\u201353. https:\/\/doi.org\/10.1002\/EJI.200424913.","journal-title":"Eur J Immunol"},{"key":"21_CR180","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.scr.2014.08.004","volume":"13","author":"L Zhao","year":"2014","unstructured":"Zhao L, Teklemariam T, Hantash BM. Heterelogous expression of mutated HLA-G decreases immunogenicity of human embryonic stem cells and their epidermal derivatives. Stem Cell Res. 2014;13:342\u201354.","journal-title":"Stem Cell Res"},{"key":"21_CR181","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/s41587-019-0016-3","volume":"37","author":"T Deuse","year":"2019","unstructured":"Deuse T, Hu X, Gravina A, Wang D, Tediashvili G, De C, et al. Hypoimmunogenic Derivatives of Induced Pluripotent Stem Cells Evade Immune Rejection in Fully Immunocompetent Allogeneic Recipients. Nat Biotechnol. 2019;37:252\u20138. https:\/\/doi.org\/10.1038\/s41587-019-0016-3.","journal-title":"Nat Biotechnol"},{"key":"21_CR182","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/ni1207-1287","volume":"8","author":"H Takizawa","year":"2007","unstructured":"Takizawa H, Manz MG, Macrophage, Tolerance. CD47\u2013SIRP-\u03b1\u2013Mediated Signals Matter. Nat Immunol 2007. 2007;8:12. https:\/\/doi.org\/10.1038\/ni1207-1287.","journal-title":"Nat Immunol 2007"},{"key":"21_CR183","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20200839","author":"T Deuse","year":"2021","unstructured":"Deuse T, Hu X, Agbor-Enoh S, Jang MK, Alawi M, Saygi C, et al. The Sirp\u03b1\u2013CD47 immune checkpoint in NK cells. J Exp Med. 2021. https:\/\/doi.org\/10.1084\/jem.20200839.","journal-title":"J Exp Med"},{"key":"21_CR184","doi-asserted-by":"publisher","first-page":"10441","DOI":"10.1073\/pnas.1902566116","volume":"116","author":"X Han","year":"2019","unstructured":"Han X, Wang M, Duan S, Franco PJ, Kenty JHR, Hedrick P, et al. Generation of Hypoimmunogenic Human Pluripotent Stem Cells. Proc Natl Acad Sci USA. 2019;116:10441\u20136. https:\/\/doi.org\/10.1073\/pnas.1902566116.","journal-title":"Proc Natl Acad Sci USA"},{"key":"21_CR185","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1182\/blood-2012-04-425397","volume":"121","author":"R Romee","year":"2013","unstructured":"Romee R, Foley B, Lenvik T, Wang Y, Zhang B, Ankarlo D, et al. NK Cell CD16 Surface Expression and Function is Regulated by a Disintegrin and Metalloprotease-17 (ADAM17). Blood. 2013;121:3599\u2013608. https:\/\/doi.org\/10.1182\/blood-2012-04-425397.","journal-title":"Blood"},{"key":"21_CR186","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PONE.0121788","volume":"10","author":"Y Jing","year":"2015","unstructured":"Jing Y, Ni Z, Wu J, Higgins LA, Markowski TW, Kaufman DS, et al. Identification of an ADAM17 cleavage region in human CD16 (Fc\u03b3riii) and the engineering of a non-cleavable version of the receptor in NK cells. PLoS One. 2015;10:e0121788. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0121788.","journal-title":"PLoS One"},{"key":"21_CR187","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1172\/JCI119616","volume":"100","author":"J Wu","year":"1997","unstructured":"Wu J, Edberg JC, Redecha PB, Bansal V, Guyre PM, Coleman K, et al. A novel polymorphism of FcgammaRIIIa (CD16) alters receptor function and predisposes to autoimmune disease. J Clin Invest. 1997;100:1059\u201370. https:\/\/doi.org\/10.1172\/JCI119616.","journal-title":"J Clin Invest"},{"key":"21_CR188","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/s43587-023-00560-5","volume":"4","author":"C Amor","year":"2024","unstructured":"Amor C, Fern\u00e1ndez-Maestre I, Chowdhury S, Ho YJ, Nadella S, Graham C, et al. Prophylactic and long-lasting efficacy of senolytic CAR T cells against age-related metabolic dysfunction. Nat Aging. 2024;4:336\u201349. https:\/\/doi.org\/10.1038\/s43587-023-00560-5.","journal-title":"Nat Aging"},{"key":"21_CR189","doi-asserted-by":"publisher","unstructured":"Amor C, Feucht J, Leibold J, Ho YJ, Zhu C, Alonso-Curbelo D et al. Senolytic CAR T cells reverse senescence-associated pathologies. Nature. (2020) 583:127\u201332. Erratum in: Nature. 2024;627(8004):E9. https:\/\/doi.org\/10.1038\/s41586-024-07197-3","DOI":"10.1038\/s41586-024-07197-3"},{"key":"21_CR190","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2025.114760","volume":"157","author":"Q Zheng","year":"2025","unstructured":"Zheng Q, Li H, Jiang Y, Yang P, Yin G, Yang L, et al. Fibroblast activation protein-targeted chimeric antigen-receptor-modified NK cells alleviate cardiac fibrosis. Int Immunopharmacol. 2025;157:114760. https:\/\/doi.org\/10.1016\/j.intimp.2025.114760.","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"21_CR191","doi-asserted-by":"publisher","DOI":"10.1186\/s40164-025-00633-8","volume":"14","author":"LV J\u00f8rgensen","year":"2025","unstructured":"J\u00f8rgensen LV, Christensen EB, Barnkob MB, Barington T. The clinical landscape of CAR NK cells. Exp Hematol Oncol. 2025;14(1):46. https:\/\/doi.org\/10.1186\/s40164-025-00633-8.","journal-title":"Exp Hematol Oncol"},{"key":"21_CR192","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.coi.2014.04.002","volume":"29","author":"R Solana","year":"2014","unstructured":"Solana R, Campos C, Pera A, Tarazona R. Shaping of NK cell subsets by aging. Curr Opin Immunol. 2014;29:56\u201361. https:\/\/doi.org\/10.1016\/j.coi.2014.04.002.","journal-title":"Curr Opin Immunol"},{"key":"21_CR193","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.953849","volume":"13","author":"A Valeri","year":"2022","unstructured":"Valeri A, Garc\u00eda-Ortiz A, Castellano E, C\u00f3rdoba L, Maroto-Mart\u00edn E, Encinas J, et al. Overcoming tumor resistance mechanisms in CAR-NK cell therapy. Front Immunol. 2022;13:953849. https:\/\/doi.org\/10.3389\/fimmu.2022.953849.","journal-title":"Front Immunol"},{"issue":"11","key":"21_CR194","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1007\/s00109-021-02123-w","volume":"99","author":"A Salminen","year":"2021","unstructured":"Salminen A. Immunosuppressive network promotes immunosenescence associated with aging and chronic inflammatory conditions. J Mol Med (Berl). 2021;99(11):1553\u201369. https:\/\/doi.org\/10.1007\/s00109-021-02123-w.","journal-title":"J Mol Med (Berl)"},{"issue":"1","key":"21_CR195","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-025-01682-6","volume":"18","author":"J Lian","year":"2025","unstructured":"Lian J, Yue Y, Yu W, Zhang Y. Immunosenescence: a key player in cancer development. J Hematol Oncol. 2025;18(1):25. https:\/\/doi.org\/10.1186\/s13045-025-01682-6.","journal-title":"J Hematol Oncol"},{"key":"21_CR196","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2025.102715","volume":"107","author":"S Qi","year":"2025","unstructured":"Qi S, Li J, Gu X, Zhang Y, Zhou W, Wang F, et al. Impacts of ageing on the efficacy of CAR-T cell therapy. Ageing Res Rev. 2025;107:102715. https:\/\/doi.org\/10.1016\/j.arr.2025.102715.","journal-title":"Ageing Res Rev"},{"issue":"5","key":"21_CR197","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1182\/blood.2020007748","volume":"137","author":"M Daher","year":"2021","unstructured":"Daher M, Basar R, Gokdemir E, Baran N, Uprety N, Nunez Cortes AK, et al. Targeting a cytokine checkpoint enhances the fitness of armored cord blood CAR-NK cells. Blood. 2021;137(5):624\u201336. https:\/\/doi.org\/10.1182\/blood.2020007748.","journal-title":"Blood"},{"issue":"1","key":"21_CR198","doi-asserted-by":"publisher","DOI":"10.1186\/s12979-025-00534-8","volume":"22","author":"Z Guo","year":"2025","unstructured":"Guo Z, Wu F, Chen Y, Xu J, Chen Z. Phenotypes, mechanisms, and therapeutic strategies of natural killer cell immunosenescence. Immun Ageing. 2025;22(1):38. https:\/\/doi.org\/10.1186\/s12979-025-00534-8.","journal-title":"Immun Ageing"},{"issue":"5","key":"21_CR199","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/s43587-025-00855-9","volume":"5","author":"G Soto-Heredero","year":"2025","unstructured":"Soto-Heredero G, Gaband\u00e9-Rodr\u00edguez E, Carrasco E, Escrig-Larena JI, de G\u00f3mez Las Heras MM, Delgado-Pulido S, et al. KLRG1 identifies regulatory T cells with mitochondrial alterations that accumulate with aging. Nat Aging. 2025;5(5):799\u2013815. https:\/\/doi.org\/10.1038\/s43587-025-00855-9.","journal-title":"Nat Aging"},{"key":"21_CR200","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.arr.2018.05.004","volume":"46","author":"C Custodero","year":"2018","unstructured":"Custodero C, Mankowski RT, Lee SA, Chen Z, Wu S, Manini TM, et al. Evidence-based nutritional and pharmacological interventions targeting chronic low-grade inflammation in middle-aged and older adults: a systematic review and meta-analysis. Ageing Res Rev. 2018;46:42\u201359. https:\/\/doi.org\/10.1016\/j.arr.2018.05.004.","journal-title":"Ageing Res Rev"},{"key":"21_CR201","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/7871814","volume":"2018","author":"SS Gounder","year":"2018","unstructured":"Gounder SS, Abdullah BJJ, Radzuanb NEIBM, Zain FDBM, Sait NBM, Chua C, et al. Effect of aging on NK cell population and their proliferation at ex vivo culture condition. Anal Cell Pathol (Amst). 2018;2018:7871814. https:\/\/doi.org\/10.1155\/2018\/7871814.","journal-title":"Anal Cell Pathol (Amst)"},{"key":"21_CR202","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2023.101814","volume":"69","author":"Y Zheng","year":"2023","unstructured":"Zheng Y, Liu Q, Goronzy JJ, Weyand CM. Immune aging - a mechanism in autoimmune disease. Semin Immunol. 2023;69:101814. https:\/\/doi.org\/10.1016\/j.smim.2023.101814.","journal-title":"Semin Immunol"}],"container-title":["Discover Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s44368-026-00021-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s44368-026-00021-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s44368-026-00021-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T06:53:34Z","timestamp":1772866414000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s44368-026-00021-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,7]]},"references-count":202,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["21"],"URL":"https:\/\/doi.org\/10.1007\/s44368-026-00021-2","relation":{},"ISSN":["3005-1185"],"issn-type":[{"value":"3005-1185","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,7]]},"assertion":[{"value":"20 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All the authors are employees of Celularity Inc.Non-financial competing interest statement: One of the co-authors, Robert J Hariri, serves as a Guest Editor for the \u201cAdvances in Cellular Immunotherapy for Aging-Related Diseases\u201d collection to which this manuscript was submitted. Professor Hariri received no financial compensation for this role and was not involved in the handling or decision-making of this manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}],"article-number":"5"}}